Decades of History Tell Anything: Biotech Near $50 Set to Soar
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Knowing when to switch from passive to active strategies can boost returns. This guide outlines practical signals, costs, and risk considerations.
27,125 articlesA cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
As oil markets shift, offshore drilling and onshore completion services offer different paths to profits. This compar...
A boutique fund recently boosted its Innoviva stake by $2.5 million, raising questions about the stock's modest 10% g...
June inflation cooled, sparking a rally in crypto markets. Ethereum led the way with a double‑digit gain, while Bitco...
Bitcoin has seen wild swings, but a bold forecast remains on the table. This article breaks down why some investors b...
SpaceX’s latest IPO disclosures raise a rare self‑awareness moment: its own push for a crowded Low Earth Orbit could ...
As tariffs reappear in the news, crypto markets respond with renewed volatility. This guide breaks down what the Trum...
Morgan Stanley files an amended S-1 for MSBT, signaling a concerted push to launch a spot Bitcoin ETF and disrupt the...
AST SpaceMobile targets a dramatic rise in value as it scales its satellite network and carrier partnerships, but pro...
XRP rallied on whispers of regulatory clarity, but the price action is tempered by cautious charts. This deep dive ex...
Base's move away from the OP Stack sent shockwaves through the crypto market. This article explains why optimism plun...
Bittensor's TAO aims to blend AI training services with blockchain incentives. After a sharp rally, investors wonder ...